Skip to main content
T

T

Executive Medical Affairs Leader | Oncology Field Medical & MSL Leadership

Talent
SpokaneMember since November 18, 2026
MSL hiringonboardingcoachinglearning & developmentperformance management at scaleMedical strategyscientific communicationmedical educationmedical informationreal-world evidencePre-launch readinessglobal launch executionindication expansionlifecycle managementMRC/PRC governanceISR oversightspeaker bureau governancecompliance in highly matrixed organizationsKOL managementcross-functional partnership with clinical development, commercial, and regulatopatient-centered leadership across U.S., Europe, and Asia-Pacific
·

Hire this person

Send a job offer directly to this candidate

MSL hiringonboardingcoachinglearning & developmentperformance management at scale

About

Medical Affairs executive with 26+ years of progressive leadership across oncology-focused biopharmaceutical and diagnostics organizations, including Amgen, AstraZeneca, Agilent, Gilead, and Summit Therapeutics. Board-certified oncology pharmacist with an MBA in Biotechnology Management. Built MSL organizations from the very first hire to 30+ professionals, led Medical Affairs for 12 global oncology launches and 24 indication expansions, and supported billion-dollar franchises including Neulasta, Tagrisso, Imfinzi, Lynparza, Trodelvy, and Xgeva/Prolia.

Pairs deep clinical oncology grounding with operational rigor: 18 years on Medical and Commercial Review Committees, multi-million-dollar budget ownership, ISR and KOL strategy, and hands-on leadership of AI integration in field medicine, including AI tools for field coaching, KOL engagement planning, and field intelligence collection at two companies.

Experience spans first-in-class bispecifics, antibody-drug conjugates, targeted therapies, immuno-oncology, supportive care biologics, and a liquid biopsy companion diagnostic, across the U.S., Europe, and Asia-Pacific.

Experience

Head of Field Medical, North America / Europe / Japan - Summit Therapeutics - Miami, Florida

(2026-03)

MSL Team Lead and Field Strategy Team Lead, Pan-Tumor Oncology

  • Leads the field medical strategy for ivonescimab, a first-in-class bispecific antibody for EGFR-mutated and first-line NSCLC, at a pre-launch company of 500+ employees.
  • Built and scaled two MSL teams and the field strategy function into a 30+ person organization of MSLs, field directors, strategy leads, and the Medical Information lead.
  • Own MRC and ISR governance for the field organization across North America, Europe, and Japan, and manage multi-million-dollar budgets.
  • Built the competitive intelligence collection platform and promotional speaker bureau governance.
  • Led the integration and rollout of AI tools for field coaching, KOL engagement planning, and field intelligence collection, introducing AI-enabled capabilities to the field medical organization.

Executive / Senior Director, MSL Team Lead and Strategy Team Lead - Gilead Sciences - Foster City, California

(2022 - 2026)

GU / GI / Thoracic Oncology / TNBC

  • Led field medical through the pre-launch and launch of TRODELVY (sacituzumab govitecan), an antibody-drug conjugate for triple-negative breast cancer, in a highly matrixed, leading pharmaceutical company.
  • Directed a 20+ person organization of MSLs, field directors, and strategy leads.
  • Managed multi-million-dollar budgets, including ISR, and oversaw MRC/PRC governance.
  • Built the competitive intelligence collection platform and promotional speaker bureau governance.
  • Led the integration and rollout of AI tools for field coaching, KOL engagement planning, and field intelligence collection, introducing AI-enabled capabilities to the field medical organization.

Head of Global Medical, North America / Europe / Asia, MSL and Medical Information - Agilent Technologies - Santa Clara, California

(2020 - 2022)

Pan-Tumor Hematology-Oncology Diagnostic Scientific Platform

  • Led the medical launch of a new oncology diagnostic, the first liquid biopsy NGS companion diagnostic (ctDx FIRST) for KRAZATI (adagrasib) in KRAS G12C NSCLC, at a leading diagnostics company.
  • Built the global MSL team across three regions and the medical call centers providing companion diagnostic and in-line diagnostic medical support.
  • Led a 20+ person organization for a leading diagnostics company.

Executive / Senior Director, MSL Team, Medical Affairs - AstraZeneca - Gaithersburg, Maryland

(2013 - 2020)

GU / GYN / Thoracic Oncology

  • Led pre-launch and launch field medical for Tagrisso (osimertinib, 3rd-generation EGFR TKI), Imfinzi (durvalumab, anti-PD-L1), and Lynparza (olaparib, PARP inhibitor) in a highly matrixed organization.
  • Built the oncology MSL team from the beginning and scaled it to 20+ across billion-dollar franchises.
  • Oversaw learning & development, ISR, MRC, and compliance governance.
  • Managed multi-million-dollar budgets and designed field strategies including KOL management and ISR.
  • Received Manager of the Year recognition in 2014 and 2015, the first time this occurred in AstraZeneca Medical Affairs.

Senior Director / Director, MSL West Region, Medical Affairs - Amgen - Thousand Oaks, California

(2008 - 2013)

Pan-Tumor Hematology-Oncology

  • Led an 8-to-10-person regional MSL team supporting multiple compounds in solid tumors and hematology across the billion-dollar Xgeva/Prolia franchise, with pre-launch and launch responsibility for Aranesp (darbepoetin alfa), Neulasta (pegfilgrastim), Vectibix (panitumumab), Xgeva (denosumab), Kepivance (palifermin), and Nplate (romiplostim).

Principal MSL, Medical Affairs, Pan-Tumor Hematology-Oncology - Amgen - Thousand Oaks, California

(2004 - 2008)

  • Held the highest MSL level, with expanded territory coverage and lead responsibility for new-hire onboarding, while supporting multiple new drug launches and indications.

Senior MSL, Medical Affairs, Pan-Tumor Hematology-Oncology - Amgen - Thousand Oaks, California

(2001 - 2004)

  • Began the Amgen field medical career that progressed from MSL to regional director over 12 years.

Staff Clinical Oncology Pharmacist (part-time) - University of Washington / Seattle Cancer Care Alliance - Seattle, Washington

(2000 - 2003)

  • Provided clinical pharmacy support in GU, GI, and lung oncology clinics, maintaining direct patient-care experience alongside industry work.

Professional Oncology Services Associate - Immunex Corporation - Seattle, Washington

(1999 - 2001)

Medical Information, Medical Communication, Adverse Events

  • Developed Medical Information Letters and field resources; staffed the call center for HCP inquiries and adverse event reporting.

Lead Research Assistant, Investigational Oncology Phase 1-2 Trials - University of Washington / Fred Hutch

(1998 - 1999)

Early Career (part-time)

Pharmacy Inpatient Intern - Group Health Cooperative - Seattle

(1996 - 1998)

Early Career (part-time)

Lead Oncology Research Associate - University of Washington Medical Center / Roosevelt Medical Clinic - Seattle

(1996 - 1998)

Early Career (part-time)

Education

MBA - Technology Management, Biotechnology - University of Washington, Michael G.

Foster

School of Business (2000 - 2002)

Doctor of Pharmacy (cum laude) - University of Washington, School of Pharmacy (1996 - 2000)

Plein Certificate in Geriatric Pharmacy - University of Washington, School of Pharmacy, Plein Center for Aging (1997 - 2000)

B.A.

  • Psychology

Skills

Executive Medical Affairs LeaderOncology Field Medical & MSL Leadership

Reviews

Related